said John T. Treace, CEO, Founder and Board Member of Treace. Surgeon design team member, Amber Shane, DPM, FACFAS, Department Chair and Residency Faculty at AdventHealth commented, “The ...

today announced that John T. Treace, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, beginning at approximately 9:00 am PT.

CEO John T. Treace expressed excitement about this new offering as a step towards broadening access to effective minimally invasive surgery. Full commercialization is expected in the second half ...

“We close 2024 with new product announcements and 12% annual revenue growth – positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of ...

"We're excited to expand our best-in-class bunion-focused portfolio with the SpeedAkin implant, furthering our commitment to improving patient outcomes," said John T. Treace, CEO, Founder ...

PONTE VEDRA, Fla., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in ...

“We close 2024 with new product announcements and 12% annual revenue growth – positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of ...

said John T. Treace, CEO, Founder and Board Member of Treace. “We look forward to further expanding surgeon access to the MicroQuad™ implant as we move into full market release within the first half ...

“The SpeedAkin™ implant leverages our proprietary SpeedPlate™ technology in a differentiated Akin osteotomy solution, further expanding our best-in-class bunion focused portfolio.” said John T. Treace ...